Botulinum toxin type A (BOTOX®) for the prophylactic treatment of chronic daily headache : A randomized, double-blind, placebo-controlled trial
- Author
- MATHEW, Ninan T1 ; FRISHBERG, Benjamin M2 ; GAWEL, Marek3 ; DIMITROVA, Rozalina4 ; GIBSON, John4 ; TURKEL, Catherine4
[1] Houston Headache Clinic, Houston, TX, United States
[2] Neurology Center, La Jolla, CA, United States
[3] Sunnybrook Women's College Health Sciences Centre, Toronto, Ontario, Canada
[4] Allergan, Inc, Irvine, CA, United States
BOTOX CDH Study Group, Canada - Source
Headache. 2005, Vol 45, Num 4, pp 293-307, 15 p ; ref : 49 ref
- Publisher
- Blackwell, Malden, MA
- Publication country
- United States
- Document type
- Article
- Language
- English
- Author keyword
- botulinum toxin type A chronic daily headache double-blind migraine headache placebo-controlled prophylaxis
- Keyword (fr)
- Bontoxilysin Chimiothérapie Chronique Complication Céphalée Cérébrovasculaire pathologie Douleur Dépistage Etude comparative Etude double insu Homme Migraine Prévention Système nerveux pathologie Traitement Appareil circulatoire pathologie Encéphale pathologie Enzyme Hydrolases Metalloendopeptidases Peptidases Système nerveux central pathologie Trouble neurologique Vaisseau sanguin pathologie
- Keyword (en)
- Bontoxilysin Chemotherapy Chronic Complication Headache Cerebrovascular disease Pain Medical screening Comparative study Double blind study Human Migraine Prevention Nervous system diseases Treatment Cardiovascular disease Cerebral disorder Enzyme Hydrolases Metalloendopeptidases Peptidases Central nervous system disease Neurological disorder Vascular disease
- Keyword (es)
- Bontoxilysin Quimioterapia Crónico Complicación Cefalea Vaso sanguíneo encéfalo patología Dolor Descubrimiento Estudio comparativo Estudio doble ciego Hombre Jaqueca Prevención Sistema nervioso patología Tratamiento Aparato circulatorio patología Encéfalo patología Enzima Hydrolases Metalloendopeptidases Peptidases Sistema nervosio central patología Trastorno neurológico Vaso sanguíneo patología
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B17 Neurology / 002B17A Nervous system (semeiology, syndromes) / 002B17A03 Headache. Facial pains. Syncopes. Epilepsia. Intracranial hypertension. Brain oedema. Cerebral palsy
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B17 Neurology / 002B17C Vascular diseases and vascular malformations of the nervous system
- Discipline
- Neurology
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 16743285
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1111/j.1526-4610.2005.05066.x 
https://dx.doi.org/10.1111/j.1526-4610.2005.05066.x
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:32:\"10.1111\/j.1526-4610.2005.05066.x\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:144:\"Botulinum toxin type A (BOTOX\u00ae) for the prophylactic treatment of chronic daily headache : A randomized, double-blind, placebo-controlled trial\";s:9:\"\u0000*\u0000jtitle\";s:8:\"Headache\";s:9:\"\u0000*\u0000stitle\";s:8:\"Headache\";s:7:\"\u0000*\u0000date\";s:4:\"2005\";s:9:\"\u0000*\u0000volume\";s:2:\"45\";s:8:\"\u0000*\u0000issue\";s:1:\"4\";s:8:\"\u0000*\u0000spage\";s:3:\"293\";s:8:\"\u0000*\u0000epage\";s:3:\"307\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0017-8748\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"MATHEW\";s:10:\"\u0000*\u0000aufirst\";s:7:\"Ninan T\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:5:{i:0;s:21:\"FRISHBERG, Benjamin M\";i:1;s:12:\"GAWEL, Marek\";i:2;s:19:\"DIMITROVA, Rozalina\";i:3;s:12:\"GIBSON, John\";i:4;s:17:\"TURKEL, Catherine\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"HEADAE\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:144:\"Botulinum toxin type A (BOTOX\u00ae) for the prophylactic treatment of chronic daily headache : A randomized, double-blind, placebo-controlled trial\";s:8:\"\u0000*\u0000place\";s:10:\"Malden, MA\";s:6:\"\u0000*\u0000pub\";s:9:\"Blackwell\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"15\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:32:\"10.1111\/j.1526-4610.2005.05066.x\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:144:\"Botulinum toxin type A (BOTOX\u00ae) for the prophylactic treatment of chronic daily headache : A randomized, double-blind, placebo-controlled trial\";s:9:\"\u0000*\u0000jtitle\";s:8:\"Headache\";s:9:\"\u0000*\u0000stitle\";s:8:\"Headache\";s:7:\"\u0000*\u0000date\";s:4:\"2005\";s:9:\"\u0000*\u0000volume\";s:2:\"45\";s:8:\"\u0000*\u0000issue\";s:1:\"4\";s:8:\"\u0000*\u0000spage\";s:3:\"293\";s:8:\"\u0000*\u0000epage\";s:3:\"307\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0017-8748\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"MATHEW\";s:10:\"\u0000*\u0000aufirst\";s:7:\"Ninan T\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:5:{i:0;s:21:\"FRISHBERG, Benjamin M\";i:1;s:12:\"GAWEL, Marek\";i:2;s:19:\"DIMITROVA, Rozalina\";i:3;s:12:\"GIBSON, John\";i:4;s:17:\"TURKEL, Catherine\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"HEADAE\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:144:\"Botulinum toxin type A (BOTOX\u00ae) for the prophylactic treatment of chronic daily headache : A randomized, double-blind, placebo-controlled trial\";s:8:\"\u0000*\u0000place\";s:10:\"Malden, MA\";s:6:\"\u0000*\u0000pub\";s:9:\"Blackwell\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"15\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:32:\"10.1111\/j.1526-4610.2005.05066.x\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:32:\"10.1111\/j.1526-4610.2005.05066.x\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:144:\"Botulinum toxin type A (BOTOX\u00ae) for the prophylactic treatment of chronic daily headache : A randomized, double-blind, placebo-controlled trial\";s:9:\"\u0000*\u0000jtitle\";s:8:\"Headache\";s:9:\"\u0000*\u0000stitle\";s:8:\"Headache\";s:7:\"\u0000*\u0000date\";s:4:\"2005\";s:9:\"\u0000*\u0000volume\";s:2:\"45\";s:8:\"\u0000*\u0000issue\";s:1:\"4\";s:8:\"\u0000*\u0000spage\";s:3:\"293\";s:8:\"\u0000*\u0000epage\";s:3:\"307\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0017-8748\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"MATHEW\";s:10:\"\u0000*\u0000aufirst\";s:7:\"Ninan T\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:5:{i:0;s:21:\"FRISHBERG, Benjamin M\";i:1;s:12:\"GAWEL, Marek\";i:2;s:19:\"DIMITROVA, Rozalina\";i:3;s:12:\"GIBSON, John\";i:4;s:17:\"TURKEL, Catherine\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"HEADAE\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:144:\"Botulinum toxin type A (BOTOX\u00ae) for the prophylactic treatment of chronic daily headache : A randomized, double-blind, placebo-controlled trial\";s:8:\"\u0000*\u0000place\";s:10:\"Malden, MA\";s:6:\"\u0000*\u0000pub\";s:9:\"Blackwell\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"15\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:32:\"10.1111\/j.1526-4610.2005.05066.x\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:144:\"Botulinum toxin type A (BOTOX\u00ae) for the prophylactic treatment of chronic daily headache : A randomized, double-blind, placebo-controlled trial\";s:9:\"\u0000*\u0000jtitle\";s:8:\"Headache\";s:9:\"\u0000*\u0000stitle\";s:8:\"Headache\";s:7:\"\u0000*\u0000date\";s:4:\"2005\";s:9:\"\u0000*\u0000volume\";s:2:\"45\";s:8:\"\u0000*\u0000issue\";s:1:\"4\";s:8:\"\u0000*\u0000spage\";s:3:\"293\";s:8:\"\u0000*\u0000epage\";s:3:\"307\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0017-8748\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"MATHEW\";s:10:\"\u0000*\u0000aufirst\";s:7:\"Ninan T\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:5:{i:0;s:21:\"FRISHBERG, Benjamin M\";i:1;s:12:\"GAWEL, Marek\";i:2;s:19:\"DIMITROVA, Rozalina\";i:3;s:12:\"GIBSON, John\";i:4;s:17:\"TURKEL, Catherine\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"HEADAE\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:144:\"Botulinum toxin type A (BOTOX\u00ae) for the prophylactic treatment of chronic daily headache : A randomized, double-blind, placebo-controlled trial\";s:8:\"\u0000*\u0000place\";s:10:\"Malden, MA\";s:6:\"\u0000*\u0000pub\";s:9:\"Blackwell\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"15\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
